Author
Driving change at Novo Nordisk
As Novo Nordisk implements a change strategy to expands its focus from diabetes to other chronic conditions like obesity, it is…
Dawn of a digital marketing era
The draft guideline of UCPMP restricts pharma companies from a lot of traditional marketing practices, however, it opens new doors…
IPM clocks Rs 123973 crores in May 2018
Cardiac therapy has moved to become the No. 1 therapy in the IPM by overtaking the anti-infective therapy
FDA chief outlines new ways to speed cancer drug approvals
The new approach is part of an effort to remove regulatory barriers that drag out reviews of promising new cancer treatments
TMH team presents Biocon’s cancer study results at ASCO Annual Meeting 2018
The results of the study conducted across 536 patients in six years clearly show that Nimotuzumab will benefit a large number of…
Lupin launches generic drug in the US
The drug is indicated for prevention and control of postpartum haemorrhage
Alembic Pharma plans Rs 720-crore CAPEX for FY19
Despite the pricing pressure and buyer consolidation, the company is betting big on the US market